Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Funds Go All In On Weight-Loss Leader; Stock Nears Highs

Rhythm stock is approaching its all-time high in a long base. Rhythm makes drugs to treat disorders due to genetic changes.

Investors Business Daily

Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

Investors Business Daily

How Boston Scientific's Surprise Setback Bolstered Two Of Its Top Rivals

Edwards Lifesciences stock jumped Wednesday after Boston Scientific said it would stop selling its rival heart-valve replacement systems.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

New ‘superbug’ antibiotic to treat sepsis and pneumonia enters last phase of testing

It is hoped that the drug zosurabalpin will be approved by the end of the decade

The Independent UK

Harris urges US against tariff hikes on pharma and microchip sectors

The Irish deputy premier has written to US Secretary for Commerce Howard Lutnick on two sectors that are key to Ireland’s economy.

Evening Standard

NHS rolls out ‘Amazon-style’ app for prescriptions to free up pharmacies

High street pharmacies including Boots have already adopted the technology

The Independent UK

Sanofi Inks A $470 Million Alzheimer's Deal, Sending This Dollar Stock Flying

Vigil Neuroscience tripled Thursday after Sanofi agreed to buy it for $470 million plus a CVR tied to its experimental Alzheimer's treatment.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Here's How Trump Plans To Tackle Drug Prices, And Why It Might Not Work

HHS unveiled the first details Tuesday on plans to tie U.S. drug prices to an international index, a so-called Most Favored Nation approach.

Investors Business Daily

Company decides not to rebuild chlorine plant with history of fires, explosions and toxic clouds

The company that operated a Georgia chlorine plant with a history of explosions and chemical fires that created toxic clouds has decided not to rebuild its Conyers manufacturing plant

The Independent UK

Bankrupt DNA testing firm 23andMe to be purchased for $256m

Drugmaker Regeneron Pharmaceuticals’ capture of genetic testing firm in bankruptcy auction raises privacy concerns

The Guardian - US

Biotechnology company Regeneron buying 23andMe for $256 million

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection

The Independent UK

High Times For German Cannabis Firm Amid Medical Boom

At an undisclosed site in Germany's Bavaria state, pharmaceutical CEO Philip Schetter opens a 75-centimetre (30-inch) thick steel door that secures his wares: vast amounts of cannabis.

International Business Times

FDA approves Novavax COVID-19 shot but with unusual restrictions

The Food and Drug Administration has approved Novavax's COVID-19 vaccine but with unusual restrictions

The Independent UK

Ozempic-maker Novo Nordisk Says CEO To Step Down

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down in the wake of "market challenges".

International Business Times

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stock Market Winners Look A Lot Alike: How To Use IBD's EPS Rating To Find Them

There's plenty of stock market winners that can perform well even if their EPS Rating isn't quite up to snuff.

Investors Business Daily

Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug

Biohaven shares plunged Thursday after the Food and Drug Administration unexpectedly delayed the review date for its rare-disease drug.

Radio France Internationale

French drug giant Sanofi plans massive US investment to counter Trump tariffs

French pharmaceutical giant Sanofi plans to invest billions of euros to expand its manufacturing in the United States, in response to President Donald Trump’s trade policies – which include threats to impose tariffs on medicines in order to increase homegrown production.

The Guardian - US

RFK Jr orders mifepristone review as anti-abortion groups push for ban

Health secretary cites ‘new data’ that emerged from flawed study conservatives are using to pressure US government

Get all your
news in one place.

100’s of premium titles.
One news app.

Radio France Internationale

European court delivers blow to EU Commission over Von der Leyen-Pfizer texts

The European Court of Justice has upheld a transparency challenge over undisclosed text messages between EU Commission President Ursula von der Leyen and Pfizer’s CEO during the Covid-19 vaccine negotiations.

The Guardian - UK

Von der Leyen’s texts with Pfizer boss can be shared, says EU’s highest court

European court of justice says no ‘plausible explanation’ given for denying New York Times access to texts from pandemic

Latin Times

RFK Jr. Admitting Big Pharma Paid Trump '$100 Million' Leaves Internet Stunned: 'Was That a Fraudian Slip?'

RFK Jr. told Americans President Trump cannot be bought while also revealing Trump accepted $100 million from Big Pharma.

Investors Business Daily

Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News

Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive products.

International Business Times

Europe's Biggest 'Green' Methanol Plant Opens In Denmark

Europe's largest "green" methanol plant opened in Denmark on Tuesday, boosting the continent's emissions reduction efforts -- with customers ranging from shipping giant Maersk to toymaker Lego and pharmaceutical firm Novo Nordisk.

Evening Standard

Nationwide eye care product recall as experts warn to stop using this product immediately

More than 1.8 million units of this eye care solution have been recalled

The Guardian - US

Trump signs order aiming to slash US drug prices to match those abroad

Health policy experts support the ‘most favored nation’ plan but doubt it will withstand likely legal challenges

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.